| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Leslie W. Kreis | 10%+ Owner | Aug 12, 2024 | |||
| Todd Thomson | Director, 16.4% Owner | Aug 12, 2024 | |||
| Jason A. Keyes | Director | Aug 12, 2024 | |||
| Paul Lytle | Chief Financial Officer | Aug 14, 2024 | |||
| Aaron G.L. Fletcher | Director, 10%+ Owner | Aug 12, 2024 | |||
| Bios Clinical Opportunity Fund, LP | 10%+ Owner | Aug 12, 2024 | |||
| Andrew Paul Mazar | Chief Operating Officer | Aug 12, 2024 | |||
| Daniel M. Schmitt | President, CEO and Director, Director | Aug 14, 2024 | |||
| Dan Zabrowski | Director | Aug 12, 2024 | |||
| Bios 2024 Co-Invest, LP | Director, Member of 10% Group | Aug 14, 2024 | |||
| Bios Equity COF, LP | Director, 10%+ Owner | Aug 12, 2024 | |||
| Roger Sawhney | Director | Aug 12, 2024 | |||
| Amy L. Ronneberg | Director | Aug 12, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|